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	1. Comprehensive	review	of	literature	to	further	elaborate	upon	the	various	treatment	modalities	for	adhesive	capsulitis.	2. Evaluate	the	effectiveness	of	both	landmark	and	US-guided	cortisone	injections	in	terms	of	VAS	scores,	SANE	scores,	and	ROM	outcomes	for	adhesive	capsulitis.	3. Compare	pain	relief	and	self-reported	function	results	of	landmark	versus	US-guided	corticosteroid	injections	for	adhesive	capsulitis.	4. Compare	the	improvement	in	shoulder	ROM	between	landmark	and	US-guided	corticosteroid	injections	for	adhesive	capsulitis.	
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METHODS	
Participants	and	Eligibility	The	BIDMC	Committee	on	Clinical	Investigations	approved	this	study	(IRB	protocol	#:	2015P000157).	This	preliminary	report	is	of	a	prospective	study	that	was	conducted	at	BIDMC	from	August	2015	through	March	of	2017.	The	purpose	of	this	study	was	to	compare	two	methods	of	intra-articular	corticosteroid	injection,	landmark	and	US	guided,	in	the	treatment	of	adhesive	capsulitis	of	the	shoulder.		Inclusion	criteria	for	the	study	were	that	patients	needed	to	be	of	the	age	18	or	older,	have	adhesive	capsulitis	of	the	shoulder	confirmed	by	the	physician,	self-reported	pain	and/or	stiffness	in	the	shoulder	for	more	than	three	months,	and	willingness	to	continue	care	at	BIDMC	Department	of	Orthopaedics	through	planned	study	follow-up.		Exclusion	criteria	for	the	study	were	previous	history	of	an	intra-articular	shoulder	corticosteroid	injection,	previous	diagnosis	of	calcific	tendonitis	or	evidence	of	calcific	tendonitis	on	X-ray,	previous	diagnosis	of	cervical	radiculopathy	or	the	presence	of	one	or	more	of	the	following	signs	on	physical	exam	(Spurling’s	sign,	neck	pain,	radiating	arm	pain	or	numbness,	sensory	defects,	and	motor	dysfunction	in	the	neck	and	upper	extremities),	radiographic	evidence	of	Os	Acromiale,	currently	receiving	protease	inhibitors,	or	suspected	full	thickness	RTC	tear,	as	identified	by	evidence	of	a	full	thickness	tear	on	MRI	or	US,	weakness	of	arm	elevation,	a	positive	“drop	arm	sign”,	or	a	high-riding	humerus	visible	on	the	shoulder	X-ray.		
	22 
From	August	2015	through	March	of	2017	there	were	a	total	of	22	patients	that	were	seen	at	BIDMC	with	a	diagnosis	of	adhesive	capsulitis	that	were	screened	for	eligibility.	Of	the	22	patients	that	were	screened,	only	one	was	omitted	due	to	exclusion	criteria	of	having	a	history	of	an	intra-articular	shoulder	corticosteroid	injection.	The	remaining	21	patients	were	included	in	the	study	after	signing	informed	consents	and	then	subsequently	being	randomized.			
Randomization	This	prospective	study	randomized	patients	into	two	different	groups.	Participants	were	randomized	into	Groups	1	and	2	through	the	use	of	the	random	number	generator	on	“random.org.”	On	this	website	the	minimum	was	set	to	1	and	the	maximum	was	set	to	two,	which	ensured	that	each	participant	had	an	equal	chance	to	be	allocated	to	either	group.	Patients	that	were	assigned	to	Group	1	received	a	blind	or	landmark	corticosteroid	injection	into	the	GH	joint	of	the	affected	shoulder.	Patients	allocated	to	Group	2	were	administered	a	corticosteroid	injection	under	US	guidance	by	a	radiologist.	All	participants	in	the	study,	regardless	of	which	group	they	were	assigned	to,	were	subjected	to	the	same	rehabilitation	protocol	that	entailed	formal	physical	therapy	for	a	total	of	six	weeks,	two	times	a	week.	Physical	therapy	consisted	of	shoulder	range	of	motion	and	strengthening	exercises,	more	specifically	those	focused	on	the	RTC	and	periscapular	region	(trapezius	and	serratus	anterior).	Posterior	capsular	stretching	was	also	utilized.	Additionally,	the	therapists	instructed	the	patients	to	supplement	physical	therapy	with	a	home	
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exercise	program	that	they	would	continue	to	implement	following	the	termination	therapy.			Four	patients	were	lost	to	follow-up	in	Group	1	because	they	could	not	attend	the	required	visits.	Two	patients	were	lost	in	Group	2,	one	due	to	inability	to	attend	a	scheduled	visit	and	the	other	due	to	an	incorrect	procedure	protocol	(patient	received	corticosteroid	injection	under	fluoroscopy	instead	of	US	guidance).	A	representative	Consilidated	Standards	of	Reporting	Trials	(CONSORT)	flow	diagram	for	the	study	is	depicted	below	(Figure	2).	
Figure	2.	Flow	diagram	of	patients	recruitment	based	on	CONSORT	criteria.	
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Intervention	 	Subsequent	to	randomization,	patients	in	Group	1	received	a	landmark	GH	joint	corticosteroid	injection	into	the	effected	shoulder.	The	landmark	injections	were	administered	in	clinic	by	one	of	the	two	orthopedic	surgeons	involved	in	the	study.	Risks	and	benefits	of	the	injection	were	discussed.	After	informed	consent	the	affected	shoulder	was	prepped	sterilely.	First,	a	dose	of	3	cc	of	1%	Lidocaine	was	administered	to	the	shoulder	to	achieve	local	anesthesia.	Following	this,	the	intra-articular	corticosteroid	injection	consisting	of	a	mixture	of	4	mL	of	10	mg/mL	Triamcinolone	Acetonide	and	1	mL	of	0.25%	Bupivacaine	was	administered.	The	injection	site	(GH	joint)	was	determined	through	the	palpation	of	anatomical	landmarks:	medial	to	the	humeral	head	and	1	cm	lateral	to	the	coracoid	process	of	the	effected	shoulder.	The	injection	was	administered	through	an	anterior	approach	with	a	22-gauge	spinal	needle	directed	posteriorly	with	a	slightly	superolateral	angle	(Figure	3).		Patients	that	were	allocated	to	Group	2	had	to	set	up	a	separate	visit	with	the	Radiology	department	of	BIDMC	to	receive	the	US-guided	injection.	These	injections	were	administered	by	one	of	the	two	radiologists	that	were	involved	in	the	study.	After	risks,	benefits,	and	informed	consent	an	US	was	performed	and	the	injection	site	was	located.	The	affected	shoulder	was	then	prepped	sterilely	and	infiltrated	with	3	cc	of	1%	Lidocaine	to	achieve	local	anesthesia.	While	under	US	visualization,	a	22-gauge	needle	was	advanced	to	the	GH	joint	and	an	injection	of	40	mg	of	10	
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mg/mL	Triamcinolone	Acetonide	and	1	mL	of	0.25%	Bupivacaine	was	administered.	After	the	injection	the	patient	was	assessed	for	any	immediate	complications	and	then	left	the	department	in	stable	condition.	There	were	no	adverse	reactions	documented	in	any	of	the	participants	from	either	group	subsequent	to	receiving	the	cortisone	injection.		 .		
	
	
	
	
	
	
	
	
	
Figure	3.	Injection	technique	used	to	administer	landmark	injections	(Group	
1).	
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Figure	4.	US-guided	injection	(Group	2).	
	
Outcome	Measurements	Clinical	and	functional	guidelines	were	documented	at	baseline	and	at	follow-ups	at	6	and	12	weeks	post-injection.	Outcome	measures	included	VAS	for	pain,	which	is	measured	on	a	0-10	scale,	with	10	being	the	most	severe	pain.	Another	outcome	measure	used	was	the	SANE	score	for	self-reported	function,	which	is	measured	on	a	0-100	scale	with	100	representing	optimal	shoulder	function.	Finally,	passive	range	of	motion	was	measured	with	the	patient	in	the	upright	position,	including	forward	flexion,	external	rotation,	and	abduction.	
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Statistical	Analysis		 The	six	patients	in	Group	1	and	the	two	patients	in	Group	2	that	were	missing	data	due	to	loss	to	follow-up	were	included	in	this	analysis	given	the	limited	number	of	participants	for	this	preliminary	report.	However,	the	patient	that	received	the	incorrect	injection	protocol	was	not	included	in	the	study.	Therefore,	the	analysis	was	performed	on	11	patients	in	the	landmark	corticosteroid	injection	group	and	9	patients	in	the	US-guided	corticosteroid	injection	group.	This	statistical	analysis	was	performed	using	SPSS	version	22.0	software.	Univariate	descriptive	statistics	were	also	used	for	demographic	information,	including	race,	ethnicity,	gender,	age,	and	affected	shoulder.	Median	and	range	were	determined	for	all	of	the	outcome	measures	(VAS,	SANE,	and	ROM:	forward	flexion,	external	rotation,	and	abduction).	Comparisons	between	groups	at	baseline	and	at	each	follow-up	(6	and	12	weeks)	for	all	outcome	measures	were	performed	with	Mann-Whitney	U	tests.	Comparisons	within	each	group	between	baseline	and	each	follow-up	period	for	all	outcome	measures	were	performed	using	the	Wilcoxon	signed	rank	test.		A	P	value	of	<.05	was	considered	statistically	significant.	
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RESULTS	The	20	patients	included	in	this	preliminary	report	consisted	of	50%	(n=10)	males	and	50%	females	(n=10).	The	ages	of	the	study	population	ranged	from	42	to	73	years	with	an	average	age	of	54	years.	Twelve	of	the	subjects	affected	shoulder	was	the	right	(60%)	and	eight	of	the	subjects	affected	shoulder	was	the	left	(40%).	With	respect	to	ethnicity,	only	10%	of	the	study	population	identified	as	Hispanic.	In	regards	to	race,	85%	of	the	participants	identified	as	White,	while	the	other	15%	of	the	participants	identified	as	Black/African	American.		
Changes	in	VAS	Scores		 The	mean	baseline	VAS	scores	were	found	to	be	similar	between	the	two	treatment	groups.	There	was	significant	improvement	seen	in	terms	of	pain	in	both	groups.	The	improvement	in	VAS	scores	in	the	two	groups	was	maintained	at	the	6	week	and	12	week	assessments	(Table	2).	Following	the	completion	of	the	12	week	treatment,	average	VAS	scores	decreased	by	4	in	the	US-guided	group	and	approximately	4.75	in	the	landmark	group.	There	was	no	significant	difference	seen	in	reduction	of	pain	between	the	US-guided	or	landmark	groups	at	either	time	point	(Figure	5).			
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Table	2.	Statistics	of	the	Differences	in	VAS	Scores	by	Time	and	Treatment	
Group	
aValues	demonstrate	mean	VAS	scores	with	ranges	in	the	parentheses.	bP	values	compare	mean	VAS	score	differences	between	baseline	and	follow-up	periods	within	each	group.	cP	values	compare	mean	VAS	score	differences	between	the	landmark	and	US-guided	groups	at	each	time	period.	
	
	
Figure	5.	Comparison	of	Changes	in	Mean	VAS	Scores	Between	Treatment	
Groups	
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Changes	in	SANE	Scores	 		 According	to	the	analysis,	mean	baseline	SANE	scores	were	similar	between	the	two	treatment	groups	(US-guided/landmark:	47.2/34.1,	P	=	.157).	There	was	significant	improvement	in	SANE	scores	for	the	landmark	and	US-guided	groups	at	both	the	6	week	and	12	week	time	periods	(Table	3).	However,	when	comparing	the	two	treatment	groups	there	were	no	significant	differences	seen	at	any	of	the	time	periods.	Overall,	the	average	SANE	scores	improved	by	56.0	in	the	landmark	group	and	35.4	in	the	US-guided	group	by	the	end	of	the	treatment.	Although	not	statistically	significant,	mean	SANE	scores	at	the	end	of	the	12	week	follow-up	period	were	90.1	in	the	landmark	group	and	82.6	in	the	US-guided	group	(Figure	6).			
	
Table	3.	Statistics	of	the	Differences	in	SANE	Scores	by	Time	and	Treatment	
Group	
aValues	demonstrate	mean	SANE	scores	with	ranges	in	the	parentheses.	bP	values	compare	mean	SANE	score	differences	between	baseline	and	follow-up	periods	within	each	group.	cP	values	compare	mean	SANE	score	differences	between	the	landmark	and	US-guided	groups	at	each	time	period.			 	
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Figure	6.	Comparison	of	Changes	in	Mean	SANE	Scores	Between	Treatment	
Groups	
	
	
Changes	in	Shoulder	ROM			 Based	on	analysis,	there	were	no	significant	differences	seen	at	baseline	between	the	two	groups	in	any	of	the	ROM	categories	(forward	flexion,	external	rotation,	or	abduction).	With	respect	to	forward	flexion,	there	was	significant	improvement	seen	in	the	US-guided	group	and	landmark	group	at	both	follow-up	visits.	There	were	no	significant	differences	seen	between	the	groups	for	forward	flexion	at	any	time	period.	In	regards	to	mean	external	rotation	outcomes,	both	groups	saw	significant	improvement	throughout	the	length	of	the	study.	Again,	there	were	no	significant	differences	seen	in	mean	external	rotation	outcomes	between	the	groups	throughout	the	treatment.	With	respect	to	mean	abduction	
	32 
outcomes,	both	the	landmark	and	US-guided	groups	significantly	improved	throughout	the	12	week	treatment	period.	There	was	a	significant	difference	seen	in	mean	abduction	outcomes	between	the	two	treatment	groups	at	the	6	week	follow-up	(P	=	.004),	in	favor	of	the	US-guided	group.	However,	the	difference	between	the	groups	lost	significance	at	the	12	week	follow-up.	
	
Table	4.	Statistics	of	the	Differences	in	ROM	Outcomes	by	Time	and	Treatment	
Group	
aValues	demonstrate	mean	ROM	scores	with	ranges	in	the	parentheses.	bP	values	compare	mean	ROM	differences	between	baseline	and	follow-up	periods	within	each	group.	cP	values	compare	mean	ROM	differences	between	the	landmark	and	US-guided	groups	at	each	time	period.		 	
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DISCUSSION		 The	principal	finding	of	this	preliminary	report	is	that	US-guided	intra-articular	cortisone	injections	showed	no	significant	differences	in	pain	reduction,	self-reported	function,	or	shoulder	ROM	outcomes	than	landmark	injections	for	adhesive	capsulitis.	US-guided	injections	were	only	found	to	significantly	improve	mean	abduction	outcomes	compared	to	landmark	injections	at	6	weeks	post-injection	(P	=	.004).	Of	note,	there	were	significant	improvements	seen	in	all	outcome	measures,	regardless	of	group	assignment,	at	both	the	6	week	and	12	week	assessments.	The	improvements	noted	at	6	weeks	were	maintained	at	the	12	week	time	period	for	all	outcome	measures	in	both	groups.		 Studies	by	Carette	et	al	(2003)	and	Ryans	et	al	(2005)	have	found	that	combining	a	corticosteroid	injection	with	PT	is	more	beneficial	than	an	injection	or	PT	alone,	in	terms	of	both	pain	and	mobility.	This	research	supports	the	inclusion	of	a	physical	therapy	regimen	for	all	participants	subsequent	to	receiving	the	injections	in	this	study.	It	is	believed	the	cortisone	injection	helps	patients	progress	through	the	stages	of	rehabilitation	faster	in	addition	to	alleviating	pain.	Prior	to	this	study,	the	only	two	other	prospective	studies	that	have	compared	US-guided	and	landmark	injections	for	adhesive	capsulitis	found	significant	differences	in	terms	of	pain	and	shoulder	motion.	However,	neither	of	these	studies	examined	the	impact	of	these	injection	techniques	alone	for	adhesive	capsulitis.		The	study	by	Lee	et	al	(2009)	found	that	US-guided	injections	provided	greater	pain	improvement	and	shoulder	mobility	two	weeks	subsequent	to	the	
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injection,	yet	followed	the	cortisone	injections	with	subsequent	hyaluronate	injections.	The	other	study	found	that	the	US-guided	injections	delivered	better	ROM	and	pain	outcomes	than	landmark	injections	at	6	weeks	post-injection	(Ucuncu	2009).	Yet,	it	did	not	observe	adhesive	capsulitis	alone	and	instead	assessed	results	for	other	shoulder	pathologies	as	well.	The	results	of	these	two	studies	conflict	with	the	findings	of	our	study,	in	which	there	were	no	significant	differences	in	any	of	the	outcome	measures	between	the	two	treatment	groups.	To	our	knowledge	this	is	the	first	study	that	has	examined	the	effects	of	landmark	and	US-guided	injections	alone	for	adhesive	capsulitis.		A	Cochrane	review	by	Bloom	et	al	(2012)	supported	the	results	found	in	our	study.	This	review	showed	that	there	were	no	significant	differences	found	between	US-guided	and	blind	cortisone	injections	in	terms	of	reduction	of	pain	or	improvement	in	shoulder	ROM	(Bloom	2012).	Another	recent	review	by	Sage	et	al	(2013)	demonstrated	that	there	is	a	significant	difference	found	in	pain	and	abduction	six	weeks	following	the	injection.	In	comparison	to	our	study,	no	significant	difference	was	found	between	the	two	groups	in	terms	of	VAS	scores	but	US-guided	significantly	improved	abduction	outcomes	compared	to	landmark	at	the	6	week	follow-up	period.	Research	surrounding	this	topic	remains	ambiguous	and	there	is	clearly	a	necessity	of	further	investigation	in	the	future.	The	completion	of	our	study	in	the	upcoming	months	will	provide	a	stronger	analysis	between	US-guided	and	landmark	injections	given	that	there	will	be	a	larger	study	population	and	more	concrete	data.		
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Given	the	findings	of	this	preliminary	report	and	the	current	research	on	the	effectiveness	of	subacromial	injections	for	frozen	shoulder	(Oh	2011,	Shin	2013,	Kim	2015),	implications	for	a	future	randomized	controlled	trial	comparing	the	efficacies	of	US-guided,	landmark,	and	subacromial	corticosteroid	injections	for	adhesive	capsulitis	should	be	considered.				
Limitations	of	This	Study	 	Limitations	of	this	preliminary	report	include	a	small	patient	population	(n=20),	in	which	several	of	the	patients	missed	at	least	one	follow-up	appointment.	Given	the	limited	study	population,	those	who	were	lost	to	follow-up	were	still	included	in	the	statistical	analysis.	This	can	have	implications	in	the	strength	and	validity	of	the	analysis,	which	in	turn	can	alter	the	conclusions	that	can	be	made.		Another	limitation	was	the	substandard	methodological	characteristics	used.	While	exclusion	criteria	included	MRI	evidence	of	a	full-thickness	RTC	tear,	only	30%	(n=6)	of	the	participants	in	the	study	underwent	an	MRI.	A	relatively	recent	study	evaluated	patients	considered	to	be	in	the	“frozen”	stage	of	adhesive	capsulitis,	in	which	approximately	one	third	had	MRI	findings	of	RTC	tears	(Yoo	2009).		Additionally,	while	duration	of	pain	for	more	than	three	months	was	an	inclusion	criterion,	the	study	did	not	specify	the	stage	of	disease	of	the	participants,	which	has	been	identified	as	a	predictor	of	prognosis	in	conservative	treatment	(Rill	2011).	Finally,	the	short-term	follow-ups	could	be	considered	as	another	limitation.	However,	several	of	the	previously	mentioned	studies	examining	the	effects	of	
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cortisone	injections	for	adhesive	capsulitis	utilized	similar	time	formats,	so	it	was	felt	that	the	12	week	treatment	period	was	appropriate	for	this	study.		
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